We are live on
!
Find out more
LBC
Lawrence B. Cohen Portfolio holdings
AUM
$2.06M
1-Year Est. Return
34.47%
This Fund
S&P 500
This Quarter
Est. Return
+3.02%
1 Year Est. Return
+34.47%
3 Year Est. Return
+41.85%
5 Year Est. Return
+126.65%
10 Year Est. Return
+272.7%
AUM
$145M
AUM Growth
+$2.43M
(+1.7%)
Cap. Flow
-$928K
Cap. Flow
% of AUM
-0.64%
Top 10 Holdings %
Top 10 Hldgs %
36.2%
Holding
74
New
6
Increased
22
Reduced
35
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$391K |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$382K |
| 3 |
AbbVie
ABBV
|
+$381K |
| 4 |
Abbott
ABT
|
+$350K |
| 5 |
Consolidated Edison
ED
|
+$224K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$1.68M |
| 2 |
Edwards Lifesciences
EW
|
+$367K |
| 3 |
Novartis
NVS
|
+$335K |
| 4 |
ExxonMobil
XOM
|
+$210K |
| 5 |
TJX Companies
TJX
|
+$199K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.72% |
| 2 | Healthcare | 19.18% |
| 3 | Financials | 12.18% |
| 4 | Industrials | 9.17% |
| 5 | Consumer Staples | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.35T
| $8.06M | 5.58% |
60,186
-860
| -1% | -$109K |
|
2
Apple
AAPL
$4.9T
| $6.57M | 4.54% |
132,740
-440
| -0.3% | -$21.4K |
|
3
Intel
INTC
$460B
| $5.89M | 4.07% |
122,951
-2,555
| -2% | -$127K |
|
4
Stryker
SYK
$133B
| $5.22M | 3.61% |
25,405
-768
| -3% | -$147K |
|
5
PepsiCo
PEP
$191B
| $5.05M | 3.5% |
38,518
+1,366
| +4% | +$175K |
|
|
6
TJX Companies
TJX
$176B
| $4.94M | 3.42% |
93,340
-3,735
| -4% | -$199K |
|
7
iShares MSCI EAFE ETF
EFA
$78.5B
| $4.61M | 3.19% |
70,069
+611
| +0.9% | +$40K |
|
8
Procter & Gamble
PG
$335B
| $4.4M | 3.05% |
40,161
+1,298
| +3% | +$138K |
|
9
US Bancorp
USB
$98B
| $3.85M | 2.67% |
73,525
-2,329
| -3% | -$120K |
|
10
Verizon
VZ
$193B
| $3.72M | 2.58% |
65,185
-395
| -0.6% | -$22.8K |
|
11
JPMorgan Chase
JPM
$933B
| $3.72M | 2.57% |
33,275
-285
| -0.8% | -$31.4K |
|
12
Comcast
CMCSA
$84B
| $3.47M | 2.4% |
82,180
-630
| -0.8% | -$26.6K |
|
13
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $3.41M | 2.36% |
11,637
-400
| -3% | -$115K |
|
|
RDS.B
14
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $3.37M | 2.33% |
51,231
-2,122
| -4% | -$138K |
|
15
Cognizant
CTSH
$24.3B
| $3.23M | 2.23% |
50,908
-1,777
| -3% | -$117K |
|
16
Rockwell Automation
ROK
$52.4B
| $3.2M | 2.22% |
19,558
-555
| -3% | -$93.8K |
|
17
Booking.com
BKNG
$150B
| $3.16M | 2.19% |
42,200
-500
| -1% | -$35.9K |
|
18
Thermo Fisher Scientific
TMO
$214B
| $2.99M | 2.07% |
10,185
+195
| +2% | +$53.7K |
|
19
Medtronic
MDT
$110B
| $2.98M | 2.07% |
30,656
-455
| -1% | -$41.5K |
|
|
20
Edwards Lifesciences
EW
$50B
| $2.9M | 2.01% |
47,079
-6,066
| -11% | -$367K |
|
21
Amazon
AMZN
$2.53T
| $2.88M | 1.99% |
30,440
+2,180
| +8% | +$203K |
|
22
CVS Health
CVS
$134B
| $2.84M | 1.97% |
52,137
-820
| -2% | -$44.2K |
|
23
Alphabet (Google) Class C
GOOG
$4.08T
| $2.79M | 1.93% |
51,600
+40
| +0.1% | +$2.31K |
|
24
Salesforce
CRM
$148B
| $2.77M | 1.91% |
18,236
-100
| -0.5% | -$15.7K |
|
|
25
Novartis
NVS
$301B
| $2.68M | 1.85% |
29,331
-3,955
| -12% | -$335K |
|
Similar funds
ICM
TA
SCM
LCMP
GIP
STC
GC
DU
Lawrence B. Cohen's Q2 2019 Portfolio in Review
As of Q2 2019, Lawrence B. Cohen held 74 positions worth $145M, up 1.7% from $142M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Lawrence B. Cohen's Q2 2019 filing shows 6 new, 22 increased, 35 reduced and 1 closed positions. Its largest new stake was Baxter International: 5,030 shares worth $412K. The largest sale was Biogen, an estimated $1.68M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Lawrence B. Cohen's largest Q2 2019 buy was Baxter International: 5,030 shares worth $412K.
- Lawrence B. Cohen added most to Pioneer Natural Resource Co. in Q2 2019, an estimated $382K increase.
- Lawrence B. Cohen's biggest Q2 2019 reduction was Edwards Lifesciences, cutting an estimated $367K.
- Lawrence B. Cohen fully exited Biogen in Q2 2019, selling an estimated $1.68M.
- Lawrence B. Cohen's ten largest holdings make up 36% of its $145M portfolio in Q2 2019.
- Lawrence B. Cohen opened 6 new positions and closed 1 in Q2 2019.
- Lawrence B. Cohen's portfolio value rose 1.7% quarter-over-quarter to $145M.
Based on Lawrence B. Cohen's 13F filing for Q2 2019, filed 1 Aug 2019.